Skip to content
science

We Believe the Only Acceptable Number for Sepsis Misdiagnosis is Zero

Every false-positive blood culture could result in patient harm.

Steripath® enables sustained, near-zero blood culture contamination rates.1

Learn More

Company
News

The Cost of Blood Culture Contamination

Blood culture contamination and false-positive results for sepsis routinely lead to unnecessary and prolonged use of broad-spectrum antibiotics, which can have harmful clinical and cost consequences. 2

Patient Harm

3 million antibiotic-resistant and Clostridioides difficile Infection (CDI) each year and 48,000 people die.

1 in 5 patient experience adverse drug event (ADE) associated with antibiotic administration in acute care hospital setting.

Wasted Resources

$6 billion is spent by our U.S. healthcare system each year on unnecessary treatment associated with false-positive blood culture results. 49

This does not include the impact blood culture contamination can have on CMS key quality outcome metrics and hospital reimbursement.

Developed by Physicians. Backed by Science. Proven Results.

The Steripath® Initial Diversion Device® is the only FDA 510(k)-cleared device platform specifically indicated to reduce blood culture contamination 3 for sepsis testing accuracy. Created by physicians, pathologists, clinical microbiologists and laboratorians, Steripath is the simple, all-in-one, evidence-backed solution that gives you the proven results you need for diagnostic stewardship to provide your patients with the best quality care.

Steripath System

Steripath

Steripath Micro System

Steripath Micro

Trusted by Hospitals & Healthcare Systems Nationwide

IDSA Logo

Clinical Infectious Diseases

Reduction in blood culture contamination through use of Initial Specimen Diversion Device

ENA Logo

Journal for Emergency Nursing

Effectiveness of a novel specimen collection system in reducing blood culture contamination rates

Healthcare Infection Society

Journal of Hospital Infection

Initial Specimen Diversion Device® reduces blood culture contamination and vancomycin use in academic medical center

American Journal of Medical Quality

Initial Specimen Diversion Device® utilization mitigates blood culture contamination across regional community hospital and acute care facility

Newsweek Award
vizient Award
Mission to zero

We’re on a mission to improve the diagnostic accuracy and timeliness of sepsis test results.

Join The Mission